Xconomy’s Digital Events →
Yours truly catching up with Craig Smith, an Xconomist, who is the co-discoverer of Enbrel and a co-founder of VLST.
Sponsored · Whitepaper
Create well-controlled, biologically relevant test systems and validate them to support FDA approvals
Acknowledging various stakeholder networks and regulatory environment variances is essential to uncover the right decision-makers in support of biologics or biosimilars
With data from IBM Watson Health, epidemiologists can describe treatment patterns, persistence & adherence to therapy
© 2007-2021, Xconomy, Inc.
Xconomy is a registered service mark of Xconomy, Inc.
All rights reserved.